87 related articles for article (PubMed ID: 38069080)
1. MiR-1287-5p inhibits triple negative breast cancer growth by interaction with phosphoinositide 3-kinase CB, thereby sensitizing cells for PI3Kinase inhibitors.
Schwarzenbacher D; Klec C; Pasculli B; Cerk S; Rinner B; Karbiener M; Ivan C; Barbano R; Ling H; Wulf-Goldenberg A; Stanzer S; Rinnerthaler G; Stoeger H; Bauernhofer T; Haybaeck J; Hoefler G; Jahn SW; Parrella P; Calin GA; Pichler M
Breast Cancer Res; 2019 Feb; 21(1):20. PubMed ID: 30709367
[TBL] [Abstract][Full Text] [Related]
2. Expression of urinary miRNAs targeting NLRs inflammasomes in bladder cancer.
Mearini E; Poli G; Cochetti G; Boni A; Egidi MG; Brancorsini S
Onco Targets Ther; 2017; 10():2665-2673. PubMed ID: 28579804
[TBL] [Abstract][Full Text] [Related]
3. The role of miRNAs as biomarkers in breast cancer.
Baylie T; Kasaw M; Getinet M; Getie G; Jemal M; Nigatu A; Ahmed H; Bogale M
Front Oncol; 2024; 14():1374821. PubMed ID: 38812786
[TBL] [Abstract][Full Text] [Related]
4. A comprehensive analysis of the prognostic characteristics of microRNAs in breast cancer.
Wang L; Wang G; Song J; Yao D; Wang Y; Chen T
Front Genet; 2024; 15():1293824. PubMed ID: 38572416
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs as promising biomarkers and potential therapeutic agents in breast cancer management: a comprehensive review.
Mohan Lal P; Hamza Siddiqui M; Soulat A; Mohan A; Tanush D; Tirath K; Raja S; Khuzzaim Khan M; Raja A; Chaulagain A; Tejwaney U
Ann Med Surg (Lond); 2024 Jun; 86(6):3543-3550. PubMed ID: 38846828
[TBL] [Abstract][Full Text] [Related]
6. MicroRNAs: Important Players in Breast Cancer Angiogenesis and Therapeutic Targets.
Hussen BM; Abdullah ST; Rasul MF; Salihi A; Ghafouri-Fard S; Hidayat HJ; Taheri M
Front Mol Biosci; 2021; 8():764025. PubMed ID: 34778378
[TBL] [Abstract][Full Text] [Related]
7. The anti-cancer properties of miR-340 plasmid-chitosan complexes (miR-340 CC) on murine model of breast cancer.
Kashefi S; Mohammadi-Yeganeh S; Ghorbani-Bidkorpeh F; Shabani M; Koochaki A; Haji Molla Hoseini M
J Drug Target; 2024 Jun; ():1-10. PubMed ID: 38805391
[TBL] [Abstract][Full Text] [Related]
8. Unraveling Biomarker Signatures in Triple-Negative Breast Cancer: A Systematic Review for Targeted Approaches.
Pastena P; Perera H; Martinino A; Kartsonis W; Giovinazzo F
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473804
[TBL] [Abstract][Full Text] [Related]
9. Prospectives of mirna gene signaling pathway in triple-negative breast cancer.
Chakkaravarthi K; Ramesh R; Palaniyandi T; Baskar G; Viswanathan S; Wahab MRA; Surendran H; Ravi M; Sivaji A
Pathol Res Pract; 2023 Aug; 248():154658. PubMed ID: 37421840
[TBL] [Abstract][Full Text] [Related]
10. miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine.
Piergentili R; Marinelli E; Cucinella G; Lopez A; Napoletano G; Gullo G; Zaami S
Noncoding RNA; 2024 Feb; 10(2):. PubMed ID: 38525735
[TBL] [Abstract][Full Text] [Related]
11. miR-877-5p as a Potential Link between Triple-Negative Breast Cancer Development and Metabolic Syndrome.
Moro J; Grinpelc A; Farré PL; Duca RB; Lacunza E; Graña KD; Scalise GD; Dalton GN; Massillo C; Piccioni F; Dimase F; Batagelj E; De Siervi A; De Luca P
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069080
[TBL] [Abstract][Full Text] [Related]
12. Clinical Identification of Dysregulated Circulating microRNAs and Their Implication in Drug Response in Triple Negative Breast Cancer (TNBC) by Target Gene Network and Meta-Analysis.
Qattan A; Al-Tweigeri T; Alkhayal W; Suleman K; Tulbah A; Amer S
Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918859
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA profiling identifies Forkhead box transcription factor M1 (FOXM1) regulated miR-186 and miR-200b alterations in triple negative breast cancer.
Hamurcu Z; Sener EF; Taheri S; Nalbantoglu U; Kokcu ND; Tahtasakal R; Cınar V; Guler A; Ozkul Y; Dönmez-Altuntas H; Ozpolat B
Cell Signal; 2021 Jul; 83():109979. PubMed ID: 33744419
[TBL] [Abstract][Full Text] [Related]
14. Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes.
Liu Y; Cai Q; Bao PP; Su Y; Cai H; Wu J; Ye F; Guo X; Zheng W; Zheng Y; Shu XO
Breast Cancer Res Treat; 2015 Jul; 152(1):183-191. PubMed ID: 26062749
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
